Kellen Scott 4
4 · DiaMedica Therapeutics Inc. · Filed Jun 3, 2024
Insider Transaction Report
Form 4
Kellen Scott
CFO & Secretary
Transactions
- Award
Stock Option (right to buy)
2024-06-01+130,000→ 130,000 totalExercise: $2.90Exp: 2034-05-31→ Common Shares (130,000 underlying)
Holdings
- 32,290
Voting Common Shares, no par value per share
Footnotes (1)
- [F1]Vests with respect to 25% of the underlying common shares on June 1, 2025 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2025.